{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:22:34Z","timestamp":1740144154127,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100008196","name":"M\u00e9decins Sans Fronti\u00e8res","doi-asserted-by":"publisher","award":["822637"],"award-info":[{"award-number":["822637"]}],"id":[{"id":"10.13039\/100008196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2028-y","type":"journal-article","created":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T06:35:39Z","timestamp":1498286139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ciprofloxacin for contacts of cases of meningococcal meningitis as an epidemic response: study protocol for a cluster-randomized trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Matthew E.","family":"Coldiron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Alcoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iza","family":"Ciglenecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Hitchings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Djibo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Laure","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Langendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca F.","family":"Grais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,24]]},"reference":[{"key":"2028_CR1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","volume":"43","author":"BM Greenwood","year":"1999","unstructured":"Greenwood BM. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;43:341\u201353.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"2028_CR2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0035-9203(02)90089-1","volume":"96","author":"AM Molesworth","year":"2002","unstructured":"Molesworth AM, Thomson MC, Connor SJ, Cresswell MP, Morse AP, Shears P, Hart CA, Cuevas LE. Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg. 2002;96:242\u20139.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"2028_CR3","first-page":"53","volume":"28","author":"L Lapeyssonnie","year":"1963","unstructured":"Lapeyssonnie L. La m\u00e9ningite c\u00e9r\u00e9brospinale en Afrique. Bull WHO. 1963;28:53\u2013114.","journal-title":"Bull. WHO."},{"issue":"Suppl 5","key":"2028_CR4","doi-asserted-by":"crossref","first-page":"S467","DOI":"10.1093\/cid\/civ499","volume":"61","author":"FVK Diomand\u00e9","year":"2015","unstructured":"Diomand\u00e9 FVK, Djingarey MH, Daugla DM, Novak RT, Kristiansen PA, Collard JM, Gamougam K, Kandolo D, Mbakuliyemo N, Mayer L, Stuart J, Clark T, Tevi-Benissan C, Perea WA, Preziosi MP, La Force FM, Caugant D, Messonnier N, Walker O, Greenwood B. Public health impact after the introduction of PsA-TT: the first 4\u00a0years. Clin Infect Dis. 2015;61 Suppl 5:S467\u201372.","journal-title":"Clin Infect Dis."},{"key":"2028_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3201\/eid2101.140256","volume":"21","author":"K Gamougam","year":"2015","unstructured":"Gamougam K, Daugla DM, Toralta J, Ngadoua C, Fermon F, Page AL, Djingarey MH, Caugant DA, Manigart O, Trotter CL, Stuart JM, Greenwood BM. Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. Emerg Infect Dis. 2015;21:115\u20138.","journal-title":"Emerg Infect Dis."},{"key":"2028_CR6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","volume":"56","author":"PA Kristiansen","year":"2013","unstructured":"Kristiansen PA, Diomand\u00e9 F, Ba AK, Sanou I, Ou\u00e9draogo AS, Ou\u00e9draogo R, Sangar\u00e9 L, Kandolo D, Ak\u00e9 F, Saga IM, Clark TA, Misegades L, Martin SW, Thomas JD, Tiendrebeogo SR, Hassan-King M, Djingarey MH, Messonnier NE, Pr\u00e9ziosi MP, Laforce FM, Caugant DA. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis. 2013;56:354\u201363.","journal-title":"Clin Infect Dis."},{"key":"2028_CR7","doi-asserted-by":"publisher","unstructured":"Funk A, Uadiale K, Kamau C, Caugant DA, Ango U, Greig J. Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in Northern Nigeria, 2013-14. PLOS Curr Outbreaks. 2014;6. doi: \n10.1371\/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518\n\n.","DOI":"10.1371\/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518"},{"key":"2028_CR8","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3201\/eid2210.160468","volume":"22","author":"CB Kretz","year":"2016","unstructured":"Kretz CB, Retchless AC, Sidikou F, Issaka B, Ousmane S, Schwartz S, Tate AH, Pana A, Njanpop-Lafourcade B-M, Nzeyimana I, Nse RO, Deghmane A-E, Hong E, Brynildsrud OB, Novak RT, Meyer SA, Oukem-Boyer OOM, Ronveaux O, Caugant DA, Taha M-K, Wang X. Whole-genome characterization of epidemic Neisseria meningitidis serogroup C and resurgence of serogroup W, Niger, 2015. Emerg Infect Dis. 2016;22:1762\u20138.","journal-title":"Emerg Infect Dis."},{"key":"2028_CR9","unstructured":"World Health Organization. Serogroup C in the meningitis belt: facing the challenge. Report of meeting held in Geneva, October 2015. 2015. p. 1\u201310."},{"key":"2028_CR10","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","volume":"369","author":"DS Stephens","year":"2007","unstructured":"Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;369:2196\u2013210.","journal-title":"Lancet."},{"key":"2028_CR11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/inthealth\/ihu062","volume":"6","author":"MJ Ferrari","year":"2014","unstructured":"Ferrari MJ, Fermon F, Nackers F, Llosa A, Magone C, Grais RF. Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria. Int Health. 2014;6:282\u201390.","journal-title":"Int Health"},{"key":"2028_CR12","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1016\/j.vaccine.2015.09.107","volume":"33","author":"CL Trotter","year":"2015","unstructured":"Trotter CL, Cibrelus L, Fernandez K, Lingani C, Ronveaux O, Stuart JM. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac\u00ae. Vaccine. 2015;33:6212\u20137.","journal-title":"Vaccine."},{"key":"2028_CR13","doi-asserted-by":"publisher","first-page":"CD004785","DOI":"10.1002\/14651858.CD004785.pub5","volume":"10","author":"A Zalmanovici Trestioreanu","year":"2013","unstructured":"Zalmanovici Trestioreanu A, Fraser A, Gafter-Gvili A, Paul M, Leibovici L. Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev. 2013;10:CD004785. doi:\n10.1002\/14651858.CD004785.pub5\n\n.","journal-title":"Cochrane Database Syst Rev."},{"key":"2028_CR14","volume-title":"Meningitis outbreak response in sub-Saharan Africa: WHO guideline","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Meningitis outbreak response in sub-Saharan Africa: WHO guideline. Geneva: WHO; 2014."},{"key":"2028_CR15","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.3201\/eid2210.160731","volume":"22","author":"ME Coldiron","year":"2016","unstructured":"Coldiron ME, Salou H, Sidikou F, Goumbi K, Djibo A, Lechevalier P, Compaor\u00e9 I, Grais RF. Case-fatality rates and sequelae resulting from Neisseria meningitidis serogroup C epidemic, Niger, 2015. Emerg Infect Dis. 2016;22:1827\u20139.","journal-title":"Emerg Infect Dis."},{"key":"2028_CR16","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1017\/S0950268815000849","volume":"143","author":"L Telisinghe","year":"2015","unstructured":"Telisinghe L, Waite TD, Gobin M, Ronveaux O, Fernandez K, Stuart JM, Scholten RJPM. Chemoprophylaxis and vaccination in preventing subsequent cases of meningococcal disease in household contacts of a case of meningococcal disease: a systematic review. Epidemiol Infect. 2015;143:2259\u201368.","journal-title":"Epidemiol Infect."},{"key":"2028_CR17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMoa1214289","volume":"370","author":"GJ Churchyard","year":"2014","unstructured":"Churchyard GJ, Fielding KL, Lewis JJ, Coetzee L, Corbett EL, Godfrey-Faussett P, Hayes RJ, Chaisson RE, Grant AD, Thibela TBST. A trial of mass isoniazid preventive therapy for tuberculosis control. N Engl J Med. 2014;370:301\u201310.","journal-title":"N Engl J Med."},{"key":"2028_CR18","doi-asserted-by":"crossref","first-page":"f3481","DOI":"10.1136\/bmj.f3481","volume":"346","author":"T Doherty","year":"2013","unstructured":"Doherty T, Tabana H, Jackson D, Naik R, Zembe W, Lombard C, Swanevelder S, Fox MP, Thorson A, Ekstr\u00f6m AM, Chopra M. Effect of home based HIV counselling and testing intervention in rural South Africa: cluster randomised trial. BMJ. 2013;346:f3481.","journal-title":"BMJ."},{"key":"2028_CR19","doi-asserted-by":"crossref","first-page":"h1019","DOI":"10.1136\/bmj.h1019","volume":"350","author":"EK Ansah","year":"2015","unstructured":"Ansah EK, Narh-Bana S, Affran-Bonful H, Bart-Plange C, Cundill B, Gyapong M, Whitty CJM. The impact of providing rapid diagnostic malaria tests on fever management in the private retail sector in Ghana: a cluster randomized trial. BMJ. 2015;350:h1019.","journal-title":"BMJ."},{"key":"2028_CR20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.2008.1018","volume":"301","author":"S Isanaka","year":"2009","unstructured":"Isanaka S, Nombela N, Djibo A, Poupard M, Van Beckhoven D, Gaboulaud V, Guerin PJ, Grais RF. Effect of preventive supplementation with ready-to-use therapeutic food on the nutritional status, mortality, and morbidity of children aged 6 to 60\u00a0months in Niger: a cluster randomized trial. JAMA. 2009;301:277\u201385.","journal-title":"JAMA."},{"issue":"August","key":"2028_CR21","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ije\/dyl129","volume":"35","author":"SM Eldridge","year":"2006","unstructured":"Eldridge SM, Ashby D, Kerry S. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol. 2006;35(August):1292\u2013300.","journal-title":"Int J Epidemiol"},{"key":"2028_CR22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0895-4356(95)00511-0","volume":"49","author":"A Donner","year":"1996","unstructured":"Donner A, Klar N. Statistical considerations in the design and analysis of community intervention trials. J Clin Epidemiol. 1996;49:435\u20139.","journal-title":"J Clin Epidemiol."},{"key":"2028_CR23","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/ije\/dyv113","volume":"44","author":"C Rutterford","year":"2015","unstructured":"Rutterford C, Copas A, Eldridge S. Methods for sample size determination in cluster randomized trials. Int J Epidemiol. 2015;44:1051\u201367.","journal-title":"Int J Epidemiol."},{"key":"2028_CR24","unstructured":"European Committee for Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1, 2017. \nhttp:\/\/www.eucast.org\n\n."},{"key":"2028_CR25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00001648-199109000-00004","volume":"2","author":"ME Halloran","year":"1991","unstructured":"Halloran ME, Struchiner CJ. Study designs for dependent happenings. Epidemiology. 1991;2:331\u20138.","journal-title":"Epidemiology."},{"key":"2028_CR26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.22237\/jmasm\/1130803680","volume":"4","author":"H Liu","year":"2005","unstructured":"Liu H, Wu T. Sample size calculation and power analysis of time-averaged difference. J Mod Appl Stat Methods. 2005;4:434\u201345.","journal-title":"J Mod Appl Stat Methods."},{"key":"2028_CR27","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/sim.1121","volume":"21","author":"S Lake","year":"2002","unstructured":"Lake S, Kammann E, Klar N, Betensky R. Sample size re-estimation in cluster randomization trials. Stat Med. 2002;21:1337\u201350.","journal-title":"Stat Med."},{"key":"2028_CR28","doi-asserted-by":"crossref","first-page":"e1001346","DOI":"10.1371\/journal.pmed.1001346","volume":"9","author":"C Weijer","year":"2012","unstructured":"Weijer C, Grimshaw JM, Eccles MP, McRae AD, White A, Brehaut JC, Taljaard M, Campbell M, Piaggio G, Elbourne D, Altman D, Isaakidis P, Ioannidis J, Edwards S, Braunholtz D, Lilford R, Stevens A, Hutton J, Eldridge S, Ashby D, Feder G, Mann H, Reyes M, Sim J, Dawson A, Taljaard M, Weijer C, Grimshaw J, Brown JB, Binik A, et al. The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials. PLoS Med. 2012;9:e1001346.","journal-title":"PLoS Med."},{"key":"2028_CR29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2105\/AJPH.2011.300389","volume":"102","author":"J Sim","year":"2012","unstructured":"Sim J, Dawson A. Informed consent and cluster-randomized trials. Am J Public Health. 2012;102:480\u20135.","journal-title":"Am J Public Health."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2028-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T06:35:57Z","timestamp":1498286157000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2028-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,24]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2028"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2028-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2017,6,24]]},"article-number":"294"}}